LifeStance Therapists & Psychiatrists Vancouver
7507 Northeast 51st Street, Vancouver
4.7(388 Google reviews)
United States
5 listed treatment centers serving Vancouver and the surrounding area.
7507 Northeast 51st Street, Vancouver
4.7(388 Google reviews)
1499 Southeast Tech Center Place, Suite 190, Vancouver
4.8(232 Google reviews)
8501 East Mill Plain Boulevard, Vancouver
4.7(130 Google reviews)
1499 Southeast Tech Center Place, Suite 170, Vancouver
4.7(50 Google reviews)
7507 Northeast 51st Street, Vancouver
4.3(46 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Vancouver.
6.2 miles away · Portland
3500 Northeast Martin Luther King Junior Boulevard, 200, Portland
4.6(314 Google reviews)
7.4 miles away · Portland
7.4 miles away · Portland
700 Northeast Multnomah Street, Suite 540, Portland
4.3(19 Google reviews)
7.9 miles away · Portland
11.5 miles away · Portland
7412 Southwest Beaverton Hillsdale Highway, Suite 106, Portland
4.9(28 Google reviews)
11.6 miles away · Beaverton
16100 Northwest Cornell Road, Suite 190, Beaverton
4.0(4 Google reviews)
For people in Vancouver considering SPRAVATO®, the financial picture involves more than the medication alone. Both the nasal spray and the supervised treatment visit, including required monitoring, may be billed. Ask for an estimate that separates these charges and explains your potential deductible, copay, or coinsurance responsibilities.
Coverage depends on your plan and the treatment setting. Prior authorization is common, and insurers may request records of earlier antidepressant trials. Ask your prescribing clinician to help gather medication names, treatment dates, doses, responses, and reasons for stopping, when available. Having those records ready can support the review, but does not guarantee approval.
Medicare coverage may fall under Part B or Part D depending on the plan and setting. Washington Medicaid may also cover treatment, but requirements and access depend on the plan. Confirm benefits directly rather than assuming that a center's acceptance of insurance means every treatment charge is covered.
Manufacturer savings programs exist for some eligible commercially insured patients; they are not for patients using government insurance. Eligibility rules apply, so ask about current terms without counting on assistance in advance.
Before starting, ask the center and insurer:
Also budget for transportation and time away from work.
This directory currently has no listed SPRAVATO® treatment center in Vancouver. The supplied directory information also identifies no other Washington cities with listed centers, so there is no nearby listed city to recommend here. This does not establish that treatment is unavailable locally. Ask your clinician or insurer for help identifying a setting, then confirm directly that it is SPRAVATO® REMS-certified and accepting patients.
Spravato is never a take-home treatment. You self-administer the nasal spray in a certified healthcare setting under direct observation. Monitoring continues for at least two hours after each dose, so allow additional time for check-in, preparation, and assessment before leaving. The care team determines when you are ready to leave.
For treatment-resistant depression, the typical labeled schedule starts twice weekly during weeks 1–4, then weekly during weeks 5–8. Maintenance visits may be weekly or every two weeks. Your prescriber individualizes the schedule; do not assume that a particular frequency is guaranteed.
Arrange for someone else to drive you home after every visit. You must not drive or operate machinery until the next day after a restful sleep. Ask the center what transportation arrangements it accepts, and make a backup plan if your usual driver becomes unavailable.
When planning time off work, account for travel, the full appointment, and the driving restriction afterward. Discuss scheduling needs early, especially if your job involves driving or machinery. Coordinating rides, caregiving, and work commitments before the first appointment can make repeated visits more manageable.
This directory currently has no listed SPRAVATO® center in Vancouver and no other listed Washington cities to suggest. Ask your clinician or insurer for help finding a treatment setting. Before scheduling, confirm directly that the setting is REMS-certified, accepts new patients, and can review your insurance. Offering esketamine alone does not establish certification for Spravato treatment.
Spravato is FDA-approved for adults with treatment-resistant depression, alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must assess your history and safety considerations; an approved indication does not guarantee eligibility.
Coverage depends on your plan and treatment setting. Medication and the observed monitoring visit may generate separate charges. Prior authorization and records of previous antidepressant trials are common requirements. Medicare and Washington Medicaid may cover treatment depending on the plan and setting. Ask your insurer about network status, authorization requirements, and your share of all charges before starting.
You administer the nasal spray yourself under direct observation in a REMS-certified healthcare setting. Staff monitor you for at least two hours after the dose, including checks related to blood pressure, sedation, dissociation, and breathing. You cannot take the medication home. Arrange a driver, and do not drive or operate machinery until the next day after a restful sleep.
Important risks include sedation, dissociation—a feeling of disconnection from yourself or your surroundings—respiratory depression, and blood pressure increases. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Discuss your medical history, medications, and substance use history openly with the prescribing clinician.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behaviors, and it does not replace hospitalization when clinically needed. Do not wait for a treatment appointment if you need urgent help. In an emergency, call or text 988, or call 911. A clinician can assess what level of care is appropriate now.
Approved uses, nearby treatment centers, and medically sourced patient guides.